Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture

Iota-Carrageenan Prevents the Replication of SARS-CoV-2 in a Human Respiratory Epithelium Cell Line in vitro

Frontiers Carrageenan From Kappaphycus alvarezii (Rhodophyta, Solieriaceae): Metabolism, Structure, Production, and Application

Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2

A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis—ICE-COVID, Trials

Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease A pragmatic multicenter, randomized, double-blind, placebo-controlled trial (CARR-COV-02

Small molecules in the treatment of COVID-19

Stresses, Free Full-Text

SARS-CoV-2 in the Environment: Its Transmission, Mitigation, and Prospective Strategies of Safety and Sustainability

Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2 - ScienceDirect

Iota-carrageenan inhibits replication of SARS-CoV-2 VOCs

BREAKING! Latest German Study Reinforces Past Research Showing Iota- Carrageenan Ability To Inhibit Replication Of All SARS-CoV-2 VOCs. - Thailand Medical News

Iota-Carrageenan Containing Lozenges for Colds and COVID-19